Contact Us

Life Sciences

Integrated Project Management Company, Inc. (IPM) is an industry leader in life sciences Consulting.

IPM’s experience within the Life Sciences industry is broad and deep. For more than 30 years, we’ve managed thousands of projects for more than 150 biotech, pharmaceutical, cell and gene therapy, and medical technology companies. Our clients range from startups to some of the world’s largest firms. We work onsite with your cross-functional experts to lead your critical projects and to ensure you meet your goals—efficiently, economically, and often ahead of schedule.

Our consultants, working individually or as a team, bring a wealth of industry experience, valuable leadership, and problem solving skills, and apply state of the art project management practices.  Our consultants have an average of 18 years’ experience and are Project Management Institute (PMP) certified. Most also hold advanced degrees (PhDs, MBAs, MS) and other certifications (Six Sigma, Lean, RAC).


Engage IPM For:

Hands on leadership of product development across the full product life cycle 

  • Research and development
  • Clinical development
  • Regulatory submissions
  • Commercial launch
  • Product lifecycle management
  • Pharmaceutical serialization

Create new or improve existing operational processes:

Responding to urgent corporate needs or organizational change

  • Managing timely and successful EU MDR implementation at every functional level
  • Assessing, diagnosing, and solving organizational/team problems
  • Mitigation of product quality regulatory problems, including recalls and remediations (e.g. 483 letters, Complete Response Letters)
  • Meeting the compliance timelines for serialization of the drug supply chain
  • Mergers and acquisitions, divestures
  • Changing the way your business operates

Contact us about your project.


“IPM provides more than just project management support; they share ownership for project deliverables and milestones. When I go to bed at night concerned about a project, I know the IPM project manager is worrying along with me.”

John Ludwig, Ph.D, Senior Vice President of Medicinal Sciences, Pfizer

“IPM has two attributes that differentiate them: the first is true commitment to client success; the second is their proactive approach to leveraging the collective talent of IPM. Their commitment to client success was exemplified by the time invested in getting to know not just my team but also our interfaces and stakeholders. When it comes to the breadth of IPM expertise, I was impressed by their rapid and effective engagement of experts from the Centers of Excellence, which facilitated delivery of solutions that met the breadth of our needs."

Vice President, Global Quality Analytical Science & Technology, who has engaged IPM at two top-tier biopharmaceutical companies

"IPM left an indelible mark. Our consultant left us with structures and processes in place that allow us to continue tracking and building our portfolio of projects and to communicate the value of our projects back to the rest of the organization."

Director, Product Management, Pharmaceutical Company

“We were aware that if we hired an IPM project manager, there would be a whole system of knowledge behind that person that would really help us as we were going through new transitions for our company—preparing for NDA, preparing for commercial—and help us better anticipate what would be ahead of us and plan for that.”

Ericka Benson, VP, Portfolio and Program Management, Catabasis Pharmaceuticals Inc.

Featured Articles

Make the Case for Crisis Management Before the Crisis

Most people would agree that it’s better to prevent a crisis than to have to deal with one. But the reality is, by their nature,…

Read Article

MedTech Compliance Crises: Avoiding, Preparing for, and Learning from Disruptive Events

This article was originally published on MasterControl’s GxP Lifeline blog as How to Avoid—but Prepare for—Compliance Crises. What happens when a medical technology company gets…

Read Article

Driving Innovation Through Changes to FDA Medical Device Regulations

The good news is that the FDA is enhancing review processes to ensure medical devices are safer and more effective. But are your new products…

Read Article

Parallel Global Submissions: Navigating the Space Between Submission and Approval

Development of a novel therapeutic takes several years of intense research and detailed planning. Because target populations are likely to be distributed over multiple regions…

Read Article

Alphabet Soup: How GxPs Impact the Quality of a Regulatory Submission

If you are confused by the many acronyms related to regulatory submissions, you are not alone. A variety of data from disparate functions must come…

Read Article

10 Tips for Leading Successful Medical Device Development Projects

Overseeing the development of a new medical device is a challenging undertaking. There are many moving parts involved in the process and risks and pitfalls…

Read Article

New Drug Commercialization

A Project Leadership Perspective on Approaching Market Access A new drug product launch is an exciting time for a pharmaceutical company. New product development is…

Read Article

Painkiller: Smooth Acquisition Integration Critical to New Product Rollout for Pharma Company

A global multi-billion-dollar specialty pharmaceutical company was acquiring a smaller company with a pipeline of pain and spasticity drugs that would complement its own R&D…

Read Article

Regulatory Expertise Eases the Way for Company’s First IND Submission

A young biopharmaceutical company developing a pipe-line of preclinical cancer immunotherapy treatments was preparing to file its first investigational new drug (IND) application with the…

Read Article